MUC5B启动子变异与间质性肺病及类风湿关节炎发病时间的关联
在Mass General Brigham Biobank中纳入1005例符合2010 ACR/EULAR标准的类风湿关节炎(RA)患者,分析MUC5B启动子变异(rs35705950 G>T)与RA相关间质性肺病(RA-ILD)及RA发病时间的关联。MUC5B启动子变异与RA-ILD(OR 3.34)、RA诊断前或诊断后2年内发生RA-ILD(OR 4.01)及55岁后发病的RA(OR 1.52)相关。作者认为该变异可能影响RA病程早期的RA-ILD风险,尤其在晚发型RA患者中。
要点
- MUC5B启动子变异与RA-ILD风险相关,多变量OR 3.34(95%CI 1.97, 5.60)。
- 该变异与RA诊断前或诊断后2年内发生RA-ILD相关,OR 4.01(95%CI 1.78, 8.80)。
- 该变异与55岁后发病的RA相关,OR 1.52(95%CI 1.08, 2.12)。
核心结论
- 常见MUC5B启动子变异与RA-ILD在RA病程中较早发生及RA发病年龄较晚相关。
- 作者认为MUC5B启动子变异可能影响RA病程早期的RA-ILD风险,尤其在晚发型RA患者中。
研究设计与样本
- 在Mass General Brigham Biobank这一多医院生物样本与临床数据收集研究中,识别符合2010 ACR/EULAR标准且有基因型信息的RA患者。
- 通过查阅所有有CT影像、肺活检或尸检结果的RA患者确定RA-ILD是否存在,并通过人工病历回顾确定RA和RA-ILD诊断日期。
- 采用多变量logistic回归估计MUC5B启动子变异状态对各结局的OR,并校正包括遗传祖先和吸烟在内的潜在混杂因素。
- 共纳入1005例有rs35705950基因型数据的RA患者,平均年龄45岁,79%为女性,81%为欧洲祖先。
主要发现
- MUC5B启动子变异见于155例(15.4%)RA患者。
- MUC5B启动子变异与RA-ILD相关,多变量OR 3.34(95%CI 1.97, 5.60)。
- MUC5B启动子变异与RA诊断前或诊断后2年内发生RA-ILD相关,OR 4.01(95%CI 1.78, 8.80)。
- MUC5B启动子变异与55岁后发病的RA相关,OR 1.52(95%CI 1.08, 2.12)。
关键数值与推荐
- RA-ILD:MUC5B启动子变异多变量OR 3.34(95%CI 1.97, 5.60)。
- RA诊断前或诊断后2年内发生RA-ILD:MUC5B启动子变异OR 4.01(95%CI 1.78, 8.80)。
- 55岁后发病的RA:MUC5B启动子变异OR 1.52(95%CI 1.08, 2.12)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the associations of the common MUC5B promoter variant with timing of RA-associated interstitial lung disease (RA-ILD) and RA onset. METHODS: We identified patients with RA meeting 2010 ACR/EULAR criteria and available genotype information in the Mass General Brigham Biobank, a multihospital biospecimen and clinical data collection research study. We determined RA-ILD presence by reviewing all RA patients who had CT imaging, lung biopsy or autopsy results. We determined the dates of RA and RA-ILD diagnoses by manual records review. We examined the associations of the MUC5B promoter variant (G>T at rs35705950) with RA-ILD, RA-ILD occurring before or within 2 years of RA diagnosis and RA diagnosis at age >55 years. We used multivariable logistic regression to estimate odds ratios (ORs) for each outcome by MUC5B promoter variant status, adjusting for potential confounders including genetic ancestry and smoking. RESULTS: We identified 1005 RA patients with available genotype data for rs35705950 (mean age 45 years, 79% female, 81% European ancestry). The MUC5B promoter variant was present in 155 (15.4%) and was associated with RA-ILD [multivariable OR 3.34 (95% CI 1.97, 5.60)], RA-ILD before or within 2 years of RA diagnosis [OR 4.01 (95% CI 1.78, 8.80)] and RA onset after age 55 years [OR 1.52 (95% CI 1.08, 2.12)]. CONCLUSIONS: The common MUC5B promoter variant was associated with RA-ILD onset earlier in the RA disease course and older age of RA onset. These findings suggest that the MUC5B promoter variant may impact RA-ILD risk early in the RA disease course, particularly in patients with older-onset RA.
引用
- McDermott G, Gill R, Gagne S, et al. Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset. Rheumatology (Oxford). 2022. PMID: 35289841. doi:10.1093/rheumatology/keac152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。